JP2016514677A5 - - Google Patents

Download PDF

Info

Publication number
JP2016514677A5
JP2016514677A5 JP2016502905A JP2016502905A JP2016514677A5 JP 2016514677 A5 JP2016514677 A5 JP 2016514677A5 JP 2016502905 A JP2016502905 A JP 2016502905A JP 2016502905 A JP2016502905 A JP 2016502905A JP 2016514677 A5 JP2016514677 A5 JP 2016514677A5
Authority
JP
Japan
Prior art keywords
composition
sodium sulfate
less
oral pharmaceutical
pharmaceutical tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016514677A (ja
JP6441890B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028805 external-priority patent/WO2014144407A1/en
Publication of JP2016514677A publication Critical patent/JP2016514677A/ja
Publication of JP2016514677A5 publication Critical patent/JP2016514677A5/ja
Application granted granted Critical
Publication of JP6441890B2 publication Critical patent/JP6441890B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502905A 2013-03-15 2014-03-14 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法 Expired - Fee Related JP6441890B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798759P 2013-03-15 2013-03-15
US61/798,759 2013-03-15
PCT/US2014/028805 WO2014144407A1 (en) 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018219465A Division JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Publications (3)

Publication Number Publication Date
JP2016514677A JP2016514677A (ja) 2016-05-23
JP2016514677A5 true JP2016514677A5 (enExample) 2017-04-13
JP6441890B2 JP6441890B2 (ja) 2018-12-19

Family

ID=50680164

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502905A Expired - Fee Related JP6441890B2 (ja) 2013-03-15 2014-03-14 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
JP2018219465A Expired - Fee Related JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018219465A Expired - Fee Related JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Country Status (25)

Country Link
US (2) US9919007B2 (enExample)
EP (2) EP3563838A1 (enExample)
JP (2) JP6441890B2 (enExample)
CN (2) CN108904462A (enExample)
AU (3) AU2014227598B2 (enExample)
BR (1) BR112015019776A2 (enExample)
CA (1) CA2903283C (enExample)
CY (1) CY1122387T1 (enExample)
DK (1) DK2968174T3 (enExample)
EA (2) EA034234B1 (enExample)
ES (1) ES2764462T3 (enExample)
HK (1) HK1214519A1 (enExample)
HR (1) HRP20192227T1 (enExample)
HU (1) HUE046754T2 (enExample)
IL (1) IL241367A0 (enExample)
LT (1) LT2968174T (enExample)
ME (1) ME03656B (enExample)
MX (1) MX377525B (enExample)
PE (1) PE20151543A1 (enExample)
PL (1) PL2968174T3 (enExample)
PT (1) PT2968174T (enExample)
RS (1) RS59667B1 (enExample)
SI (1) SI2968174T1 (enExample)
SM (1) SMT201900716T1 (enExample)
WO (1) WO2014144407A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3563838A1 (en) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof
EP3191105A4 (en) * 2014-09-12 2018-05-02 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
WO2018142403A1 (en) 2017-02-02 2018-08-09 Panaxia Pharmaceutical Industries Ltd. Composition for buccal or sublingual administration of cannabis extract and methods for making same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR20230124560A (ko) * 2020-10-26 2023-08-25 브레인트리 라보라토리이즈, 인코포레이티드 결장 세정을 위한 술페이트 염 제제
CN116509809B (zh) * 2023-04-19 2024-12-03 山东齐都药业有限公司 复方硫酸钠片剂及其制备方法与应用
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873694A (en) 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5438167B2 (enExample) 1974-04-27 1979-11-19
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3134591A1 (de) 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
EP0080862B1 (en) 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
JP2509594B2 (ja) 1985-08-01 1996-06-19 ブレインツリ−・ラボラトリ−ズ・インコ−ポレ−テッド 低ナトリウム緩下剤および洗浄剤処方
US4753801A (en) 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
NO168563C (no) 1987-09-28 1992-03-11 Collett Marwell Hauge As Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv
JPH0194937A (ja) * 1987-10-06 1989-04-13 Yokohama Yushi Kogyo Kk 微粉状ミネラル類の被覆物の製造方法
US4837030A (en) 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US5211958A (en) 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE3889547T2 (de) 1987-12-24 1994-11-17 Borody Thomas J Orthostatische waschlösungen.
AU3367589A (en) 1988-04-05 1989-11-03 Dale Driver Dietary mineral sulfur supplement
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
IT1229568B (it) 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
CZ218394A3 (en) 1992-03-11 1995-01-18 Procter & Gamble Plantain drinking mixtures containing granulated base
WO1994012191A1 (en) 1992-11-24 1994-06-09 Block Drug Company, Inc. Pharmaceutical compositions for use in gastrointestinal washes
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5498425A (en) 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
DK0858326T3 (da) 1996-05-08 2003-07-07 Craig A Aronchick Ikke-vandige colonafføringsmidler
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
EP0975327B1 (en) 1997-04-18 2003-07-02 Janssen Pharmaceutica N.V. Use of 5ht3 antagonists for promoting intestinal lavage
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
JP2002528483A (ja) 1998-10-30 2002-09-03 マクニール−ピーピーシー・インコーポレイテッド 顆粒状で自由流動性の薬剤組成物、およびその経口投与のためのストロー状の投与形態
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
AUPR590701A0 (en) 2001-06-25 2001-07-19 Colocaps Pty Ltd Laxative preparation
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7291324B2 (en) 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
SI1663257T1 (sl) 2003-07-09 2009-06-30 Braintree Lab Uporaba odvajal za zdravljenje sindroma razdraĺ˝ljivega äśrevesja
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
EP1750702B1 (en) 2004-06-04 2010-08-04 Braintree Laboratories, Inc. Method of bowel cleansing
WO2007013093A2 (en) 2005-04-01 2007-02-01 Shiv Prakash Laxative formulation containing a triphala extract
WO2006118562A1 (en) 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
JP5276435B2 (ja) 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ, インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
US20070087056A1 (en) 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070082061A1 (en) 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
WO2007079000A2 (en) 2005-12-29 2007-07-12 Braintree Laboratories, Inc. Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
NZ580999A (en) 2007-05-17 2012-05-25 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
US20100297264A1 (en) 2007-10-17 2010-11-25 Thomas Jefferson University Bowel purgative and uses thereof
WO2009092039A1 (en) 2008-01-16 2009-07-23 Braintree Laboratories, Inc. Sulfate salt prophylaxis and therapies
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
AU2009244190B2 (en) 2008-05-07 2016-02-25 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
US20100255122A1 (en) 2009-04-02 2010-10-07 Garren Mary L Edible gelatin bowel preparation and bowel cleansing method
AU2010239378B2 (en) 2009-04-21 2013-11-21 Dark Canyon Laboratories, Llc Colon lavage system
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
GB0912487D0 (en) 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
AU2011226324B2 (en) 2010-03-10 2015-09-24 Nogra Pharma Limited Compositions for colon lavage and methods of making and using same
EP2544543A1 (en) 2010-03-12 2013-01-16 Scott Cordray Method of treatment
JP5665372B2 (ja) * 2010-06-02 2015-02-04 旭化成ケミカルズ株式会社 速崩壊性固形製剤
EP2598123A1 (en) 2010-07-27 2013-06-05 Norgine BV Compositions
NL2007716C2 (en) 2010-11-04 2012-11-13 Norgine Bv Formulations.
CA2821196C (en) 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
JP5876418B2 (ja) * 2010-12-28 2016-03-02 大鵬薬品工業株式会社 口腔内崩壊錠剤
BR112013019360A2 (pt) 2011-01-28 2017-03-28 A Shaver William ingredientes, componente seco de formulação oral de baixo teor de cloreto farmaceuticamente aceitável para limpeza de cólon, solução de base de reposição de eletrólito aquosa para uso em lavagem colônica, métodos para limpar os intestinos de paciente, para preparar solução aquosa para limpeza do cólon e para aumentar substancialmente o paladar de limpador de cólon e kits para evacuação do cólon.
BR112013019418B1 (pt) 2011-01-31 2022-03-29 Norgine Bv Solução aquosa de peg, seus usos no tratamento de constipação e/ou impactação fecal e kit
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
HRP20171853T1 (hr) 2011-04-15 2018-02-23 Braintree Laboratories, Inc. Sulfatne soli kao ubrzivači vremena prolaska
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
WO2013044085A1 (en) 2011-09-23 2013-03-28 Subramanian Veerappan Sellappan A solid, edible, chewable laxative composition
BR112014009946A2 (pt) 2011-10-27 2017-04-25 Salix Pharmaceuticals Inc "composição, composição farmacêutica ou formulação purgativas e uso das mesmas"
US9149493B2 (en) 2011-11-28 2015-10-06 Alfa Wassermann Spa Compositions for bowel cleansing and use thereof
BR112015004165A2 (pt) 2012-08-29 2017-07-04 Salix Pharmaceuticals Inc métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations
EP3563838A1 (en) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2016514677A5 (enExample)
JP7028829B2 (ja) 口腔内崩壊錠及びその製造方法
CN106456550A (zh) 避免乙醇剂量倾泻的多颗粒
JP2016540021A5 (enExample)
JP2017525712A5 (enExample)
JP2016516698A5 (enExample)
JP2014501267A (ja) メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法
JP2016508516A5 (enExample)
Kopecky et al. Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation
JP7674080B2 (ja) アビラテロン酢酸エステル含有製剤
JP2010143836A (ja) 口腔内崩壊錠用組成物
JP2020509052A5 (enExample)
CN109646412A (zh) 一种肠溶药用组合物及其制备方法和应用
JP6580414B2 (ja) 生薬末含有錠剤
JP5347092B2 (ja) アンドログラフィス抽出物製剤
EP3270911A1 (en) Pharmaceutical compositions of dimethyl fumarate
WO2016012898A1 (en) Oral pharmaceutical composition of lurasidone
JP7407364B2 (ja) ラメルテオン含有固形製剤
JP6485120B2 (ja) 固形製剤
JP7133811B2 (ja) 錠剤
JP6927763B2 (ja) 清肺湯エキス末を含有する錠剤
JP5710301B2 (ja) 口腔内崩壊型錠及びその製造方法
KR20070119654A (ko) 의약용 조성물
IL273627B1 (en) Abuse deterrent morphine sulfate dosage forms
JP6824816B2 (ja) 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物